346 related articles for article (PubMed ID: 35973562)
1. The role of sphingolipids in meibomian gland dysfunction and ocular surface inflammation.
Paranjpe V; Galor A; Grambergs R; Mandal N
Ocul Surf; 2022 Oct; 26():100-110. PubMed ID: 35973562
[TBL] [Abstract][Full Text] [Related]
2. Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum sphingolipid composition.
Paranjpe V; Tan J; Nguyen J; Lee J; Allegood J; Galor A; Mandal N
Ocul Surf; 2019 Apr; 17(2):318-326. PubMed ID: 30553001
[TBL] [Abstract][Full Text] [Related]
3. Relationships between ocular surface sphingomyelinases, Meibum and Tear Sphingolipids, and clinical parameters of meibomian gland dysfunction.
Sanchez V; Galor A; Jensen K; Mondal K; Mandal N
Ocul Surf; 2022 Jul; 25():101-107. PubMed ID: 35714913
[TBL] [Abstract][Full Text] [Related]
4. Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids.
Galor A; Sanchez V; Jensen A; Burton M; Maus K; Stephenson D; Chalfant C; Mandal N
Ocul Surf; 2022 Jan; 23():87-95. PubMed ID: 34861426
[TBL] [Abstract][Full Text] [Related]
5. Role of Bioactive Sphingolipids in Inflammation and Eye Diseases.
Mondal K; Mandal N
Adv Exp Med Biol; 2019; 1161():149-167. PubMed ID: 31562629
[TBL] [Abstract][Full Text] [Related]
6. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
Hait NC; Maiti A
Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
[TBL] [Abstract][Full Text] [Related]
7. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
9. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Ocular Diseases and Sphingolipid Signaling.
Grambergs R; Mondal K; Mandal N
Adv Exp Med Biol; 2019; 1159():139-152. PubMed ID: 31502203
[TBL] [Abstract][Full Text] [Related]
11. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipids in cancer.
Furuya H; Shimizu Y; Kawamori T
Cancer Metastasis Rev; 2011 Dec; 30(3-4):567-76. PubMed ID: 22005951
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids in inflammation: roles and implications.
Pettus BJ; Chalfant CE; Hannun YA
Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
[TBL] [Abstract][Full Text] [Related]
14. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
16. Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: Standard operating procedures.
Ambaw YA; Timbadia DP; Raida M; Torta F; Wenk MR; Tong L
Ocul Surf; 2022 Oct; 26():318-327. PubMed ID: 33022413
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and ceramide-1-phosphate promote migration, pro-inflammatory and pro-fibrotic responses in retinal pigment epithelium cells.
Simón MV; Vera MS; Tenconi PE; Soto T; Prado Spalm FH; Torlaschi C; Mateos MV; Rotstein NP
Exp Eye Res; 2022 Nov; 224():109222. PubMed ID: 36041511
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again.
Oskouian B; Saba J
Cell Cycle; 2007 Mar; 6(5):522-7. PubMed ID: 17361098
[TBL] [Abstract][Full Text] [Related]
19. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
20. The role of sphingolipids in respiratory disease.
Yang Y; Uhlig S
Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
